Search by Drug Name or NDC
NDC 72903-0853-01 ELAHERE 100 mg/20mL Details
ELAHERE 100 mg/20mL
ELAHERE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ImmunoGen, Inc.. The primary component is MIRVETUXIMAB SORAVTANSINE.
Product Information
| NDC | 72903-0853 |
|---|---|
| Product ID | 72903-853_73674b49-1932-4e06-aef7-f37c0d50d121 |
| Associated GPIs | |
| GCN Sequence Number | 084041 |
| GCN Sequence Number Description | mirvetuximab soravtansine-gynx VIAL 100MG/20ML INTRAVEN |
| HIC3 | V1K |
| HIC3 Description | ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES |
| GCN | 53168 |
| HICL Sequence Number | 048453 |
| HICL Sequence Number Description | MIRVETUXIMAB SORAVTANSINE-GYNX |
| Brand/Generic | Brand |
| Proprietary Name | ELAHERE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | mirvetuximab soravtansine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/20mL |
| Substance Name | MIRVETUXIMAB SORAVTANSINE |
| Labeler Name | ImmunoGen, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761310 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72903-0853-01 (72903085301)
| NDC Package Code | 72903-853-01 |
|---|---|
| Billing NDC | 72903085301 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2022-11-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |